Volumen 5, Ausgabe 2 (2015)
Klinische Trail-Perspektive
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical-Trail-Methode
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Ergebnisse klinischer Studien
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Arzneimittelbewertung
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Ergebnisse klinischer Studien
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Ergebnisse klinischer Studien
Antibiotic treatment in exacerbations of chronic obstructive pulmonary disease: recent trial results
Kavina Manalan, Taslima Rashid & Aran Singanayagam
Arzneimittelbewertung
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
